- Home
- BRTX vs IMCC Comparison
BRTX vs IMCC Comparison
Compare BRTX & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- IMCC
- Stock Information
- Founded
- BRTX 1997
- IMCC 1980
- Country
- BRTX United States
- IMCC Israel
- Employees
- BRTX N/A
- IMCC N/A
- Industry
- BRTX Managed Health Care
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- BRTX Health Care
- IMCC Health Care
- Exchange
- BRTX Nasdaq
- IMCC Nasdaq
- Market Cap
- BRTX 12.5M
- IMCC 11.8M
- IPO Year
- BRTX N/A
- IMCC N/A
- Fundamental
- Price
- BRTX $1.84
- IMCC $2.32
- Analyst Decision
- BRTX
- IMCC
- Analyst Count
- BRTX 0
- IMCC 0
- Target Price
- BRTX N/A
- IMCC N/A
- AVG Volume (30 Days)
- BRTX 88.0K
- IMCC 43.8K
- Earning Date
- BRTX 08-12-2025
- IMCC 08-12-2025
- Dividend Yield
- BRTX N/A
- IMCC N/A
- EPS Growth
- BRTX N/A
- IMCC N/A
- EPS
- BRTX N/A
- IMCC N/A
- Revenue
- BRTX $605,200.00
- IMCC $38,430,631.00
- Revenue This Year
- BRTX $232.67
- IMCC $47.12
- Revenue Next Year
- BRTX $52.92
- IMCC $12.83
- P/E Ratio
- BRTX N/A
- IMCC N/A
- Revenue Growth
- BRTX 247.62
- IMCC 5.08
- 52 Week Low
- BRTX $1.21
- IMCC $1.29
- 52 Week High
- BRTX $2.55
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- BRTX 72.78
- IMCC 42.98
- Support Level
- BRTX $1.51
- IMCC $2.18
- Resistance Level
- BRTX $1.56
- IMCC $2.61
- Average True Range (ATR)
- BRTX 0.08
- IMCC 0.27
- MACD
- BRTX 0.04
- IMCC -0.01
- Stochastic Oscillator
- BRTX 89.91
- IMCC 17.35
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.